In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for ...

The FDA announced draft guidance to cut red tape on biosimilar production and access in the hopes of reducing prescription ...

We need to find ways to lower prescription prices, and it seemed like President Donald Trump was working on a promising ...

Vizz (aceclidine ophthalmic solution) eye drops can improve near vision for up to 10 hours. Learn how the drops work and ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...

Fewer choices may be on the menu again as Medicare patients shop for prescription coverage this fall. The number of available, stand-alone drug plans has fallen for a few years, and that trend will ...

Competition to create new brand-name drugs is a key driver of innovation in the United States. Unfortunately, it also drives the relentless growth of healthcare spending. That’s because development of ...

Medicare is a federal program intended to provide a basic level of health care for people age 65 and older. Bill Oxford / Getty Images Fewer choices may be on the menu again as Medicare patients shop ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

We've all seen them: 30-second television ads from attorneys, targeting those who've had a negative side effect after using a ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...